SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Swift168_YY
Lv1
90 积分
2021-03-05 加入
最近求助
最近应助
互助留言
Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics
3天前
已完结
EZH2-mediated development of therapeutic resistance in cancer
6天前
已完结
Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine
7天前
已完结
Going beyond Polycomb: EZH2 functions in prostate cancer
7天前
已完结
Structural classification of EZH2 inhibitors and prospects for the treatment of tumor: a review
7天前
已完结
Efficacy of venetoclax plus anti-CD38 monoclonal antibody-containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody
8天前
已完结
Venetoclax and Daratumumab combination treatment demonstrates pre-clinical efficacy in mouse models of Acute Myeloid Leukemia
8天前
已完结
Emerging mechanisms of enzalutamide resistance in prostate cancer
1个月前
已完结
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
2个月前
已关闭
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
2个月前
已完结
没有进行任何应助
已找到【积分已退回】
2个月前
自己已经找到了【积分已退回】
3个月前
我已经下载好了正文,我需要的是supplementary ,你给我上传的还是正文啊
11个月前
我不是要正文,正文我已经下载好了,我要的是补充supplementary 材料,但是这个给我的还是正文啊
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论